Natural history and epidemiology of hepatitis C

Journal of the Association of Nurses in AIDS Care

Volumn 14, Issue 5 SUPPL., 2003, Pages 18S-25S

  Rhoads, Jacqueline ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Hepatitis C; Modes of transmission; Natural history

Indexed keywords

COCAINE; ILLICIT DRUG; STEROID; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOOD TRANSFUSION; CLINICAL FEATURE; DISEASE PREDISPOSITION; EPIDEMIOLOGICAL DATA; HEALTH CARE COST; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HOSPITAL INFECTION; INFECTION RISK; MORBIDITY; MORTALITY; NURSING; OCCUPATIONAL EXPOSURE; ORGAN TRANSPLANTATION; REVIEW; RISK ASSESSMENT; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; UNITED STATES; CHRONIC DISEASE; CROSS INFECTION; DISEASE TRANSMISSION; HUMAN; ISOLATION AND PURIFICATION; PATHOGENICITY; PATHOPHYSIOLOGY; RISK FACTOR; SEXUAL BEHAVIOR; SUBSTANCE ABUSE;

BLOOD TRANSFUSION; CHRONIC DISEASE; CROSS INFECTION; DISEASE TRANSMISSION, HORIZONTAL; DISEASE TRANSMISSION, VERTICAL; HEPACIVIRUS; HEPATITIS C; HUMANS; OCCUPATIONAL EXPOSURE; RISK FACTORS; RNA, VIRAL; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES, VIRAL; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 0642340730     PISSN: 10553290     EISSN: None     Source Type: Journal    
DOI: 10.1177/1055329003254854     Document Type: Article

References (41)

1. Alter, M. (1997a). The epidemiology of acute and chronic hepatitis C. Clinics in Liver Disease, 1, 559-568.
2. Alter, M. (1997b). Epidemiology of hepatitis C. Hepatology, 26(Suppl.), 62S-65S.
3. Centers for Disease Control and Prevention. (1995). Update: Recommendations to prevent hepatitis B virus transmission - United States. Morbidity and Mortality Weekly Report, 44, 574-575.
4. Centers for Disease Control and Prevention. (1996). Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report, 45(RR-15), 1-30.
5. Centers for Disease Control and Prevention. (1997a). Immunization of health-care workers: Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). Morbidity and Mortality Weekly Report, 46(RR-18), 603-606.
6. Centers for Disease Control and Prevention. (1997b). Recommendations for follow-up of health-care workers after occupational exposure to hepatitis C virus [Notice to Readers]. Morbidity and Mortality Weekly Report, 46, 603-606.
7. Centers for Disease Control and Prevention. (1998). Guidelines for treatment of sexually transmitted diseases. Morbidity and Mortality Weekly Report, 47(RR-1), 1-118.
8. Conroy-Cantilena, C., VanRaden, M., Gibble, J., Melpolder, J., Shakil, A. O., Viladomiu, L., et al. (1996). Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. New England Journal of Medicine, 334, 1691-1696.
9. Crowe, J., Doyle, C., Fielding, J., Christensen, E., Doniach, D., Popper, H., et al. (1995). Presentation of hepatitis C in a unique uniform cohort 17 years from inoculation [Abstract]. Gastroenterology, 108, A1054.
10. Dufour, M. (1994). Chronic liver disease and cirrhosis. In J. E. Everhart (Ed.), Digestive diseases in the United States: Epidemiology and impact (U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, NIH Publication No. 94-1447; pp. 615-645). Washington, DC: Government Printing Office.
11. Esteban, J., Gomez, J., Martell, M., Cabot, B., Quer, J., Camps, J., et al. (1996). Transmission of hepatitis C virus by a cardiac surgeon. New England Journal of Medicine, 334, 555-560.
12. Fattovich, G., Giustina, G., Degos, F., Tremolada, F., Diodati, G., Almasio, P., et al. (1997). Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients. Gastroenterology, 112, 463-472.
13. Favero, M., & Alter, M. (1996). The reemergence of hepatitis B virus infection in hemodialysis centers. Seminars in Dialysis, 9, 373-374.
14. Garfein, R., Doherty, M., Monterroso, E., Thomas, D., Nelson, K., & Vlahov, D. (1998). Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. Journal Acquired Immune Deficiency Syndrome Hum Retrovirol, 18(Suppl. 1), 11-19.
15. Garfein, R., Vlahov, D., Galai, N., Doherty, M., & Nelson, K. (1996). Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. American Journal of Public Health, 86, 655-661.
16. Giacchino, R., Picciotto, A., Tasso, L., Timitilli, A., & Sinelli, N. (1995). Vertical transmission of hepatitis C. Lancet, 345, 1122-1123.
17. Gostin, L., Lazzarini, Z., Jones, T., & Flaherty, K. (1997). Prevention of HIV/AIDS and other blood-borne diseases among injection drug users: A national survey on the regulation of syringes and needles. Journal of the American Medical Association, 277, 53-62.
18. Gretch, D. (1997). Diagnostic tests for hepatitis C. Hepatology, 26(Suppl.), 43S-47S.
19. Groseclose, S., Weinstein, B., Jones, T., Valleroy, L., Fehrs, L., & Kassler, W. (1995). Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers - Connecticut, 1992-1993. Journal of AIDS, 10, 82-89.
20. Hagan, H., Des Jarlais, D., Friedman, S., Purchase, D., & Alter, M. (1995). Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. American Journal of Public Health, 85, 1531-1537.
21. Heimer, R., Khoshnood, K., Jariwala-Freeman, B., Duncan, B., & Harima, Y. (1996). Hepatitis in used syringes: The limits of sensitivity of techniques to detect hepatitis B virus (HBV) DNA, hepatitis C virus (HCV) RNA, and antibodies to HBV core and HCV antigens. Journal of Infectious Disease, 173, 997-1000.
22. Koff, R., & Dienstag, J. (1995). Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Seminars Liver Disease, 15, 101-109.
23. Lin, H., Kao, J., Hsu, H., Du, X., Jiang, F., Shen, H., et al. (1995). Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers. Journal of Pediatrics, 126, 589-591.
24. Mansell, C., & Locarnini, S. (1995). Epidemiology of hepatitis C in the east. Seminars Liver Disease, 15, 15-32.
25. Manzini, P., Saracco, G., Cerchier, A., Riva, C., Musso, A., Ricotti, E., et al. (1995). Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission: Persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern. Hepatology, 21, 328-332.
26. McQuillan, G., Alter, M., Moyer, L., Lambert, S., & Margolis, H. (1997). A population based serologic study of hepatitis C virus infection in the United States. In M. Rizzetto, R. H. Purcell, J. L. Gerin, & G. Verme (Eds.), Viral Hepatitis and Liver Disease (pp. 267-270). Turin, Italy: Edizioni Minerva Medica.
27. National Institutes of Health. (1997). National Institutes of Health Consensus Development Conference Panel Statement: Management of Hepatitis C. Hepatology, 26(Suppl.), 2S-10S.
28. Poynard, T., Bedossa, P., Chevallier, M., Mathurin, P., Lemonnier, C., Trepo, C., et al. (1995). A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group. New England Journal of Medicine, 332, 1457-1462.
29. Poynard, T., Bedossa, P., & Opolon, P. (1997). Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet, 349, 825-832.
30. Resti, M., Azzari, C., Lega, L., Rossi, M. E., Zammarchi, E., Novembre, E., et al. (1995). Mother-to-infant transmission of hepatitis C virus. Acta Paediatr, 84, 251-255.
31. Schvarcz, R., Johansson, B., Nyström, B., & Sönnerborg, A. (1997). Nosocomial transmission of hepatitis C virus. Infection, 25, 74-77.
32. Schvarcz, R., Yun, Z., Sonnerborg, A., & Weiland, O. (1995). Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone. Journal of Medical Virology, 46, 43-47.
33. Shakil, A., Conry-Cantilena, C., Alter, H., Hayashi, P., Kleiner, D. E., Tedeschi, V., et al. (1995). Volunteer blood donors with antibody to hepatitis C virus: Clinical, biochemical, virologic, and histologic features. Annals of Internal Medicine, 123, 330-337.
34. Thomas, D., Villano, S., Riester, K., Hershow, R., Mofenson, L. M., Landesman, S. H., et al. (1998). Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers: Women and infants transmission study. Journal of Infectious Disease, 177, 1480-1488.
35. Thomas, D., Zenilman, J., Alter, H., Shih, J. W., Galai, N., Carella, A. V., et al. (1995). Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore - An analysis of 309 sex partnerships. Journal of Infectious Disease, 171, 768-775.
36. Tong, M., Lai, P., Hwang, S.-J. (1995). Evaluation of sexual transmission in patients with hepatitis C infection. Clinical and Diagnostic Virology, 3, 39-47.
37. U.S. Preventive Services Task Force. (1996). Guide to clinical preventive services (2nd ed.). Baltimore: Williams & Wilkins.
38. Valleroy, L., Weinstein, B., Jones, T., Groseclose, S., Rolfs, R., & Kassler, W. (1995). Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales - Connecticut, 1992-1993. Journal of Acquired Immune Deficiency Syndrome Human Retrovirology, 10, 73-81.
39. Villano, S., Vlahov, D., Nelson, K., Lyles, C., Cohn, S., & Thomas, D. (1997). Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. Journal of Clinical Microbiology, 35, 3274-3277.
40. Williams, A., Thomson, R., Schreiber, G., Watanabe, K., Bethel, J. L. A., Kleinman, S. H., et al. (1997). Estimates of infectious disease risk factors in U.S. blood donors. Journal of the American Medical Association, 277, 967-972.
41. Zuccotti, G., Ribero, M., Giovannini, M., Fasola, M., Riva, E., Portera, G., et al. (1995). Effect of hepatitis C genotype on mother-to-infant transmission of virus. Journal of Pediatrics, 127, 278-280.